Thu, Aug 21, 2014, 9:15 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • thirdmeinvestor thirdmeinvestor Aug 19, 2008 10:39 PM Flag

    LMAO, the 16 pnts were fm low-riba control arm

    Paul, you did not miss any newer press release except this morning's PR for Ph III for treatment-failed pts.
    I put some old and new numbers together to see where the consistency problem is with BOC data. The biggest problem I see and you saw already is the 48wk dosing arm. The % discontinued patients is 26% for the 28wk lead-in dosing, and 28% without lead-in. These arms were dosed with Boc for 24 wks or 28 wks. Since the 48wk arms were dosed with Boc for either 44 wks or 48 wks, the % discontinued should be well beyond 26~28%. It should be around 40%. If so, the ITT based SVR for the 48 wk should be less than 60%, not 66% or 73%. This is the biggest consistency problem I see in SPRINT-1 data.

 
VRTX
88.99-2.31(-2.53%)Aug 21 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.